Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Methsuximide bulk supplier for pharma manufacturers

Methsuximide 150 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 150 mg

Reference Brands: Celontin (USA)

Category: Neurology

Methsuximide is a succinimide anticonvulsant that helps reduce abnormal electrical activity in the brain. It is prescribed for controlling absence seizures when other medications fail to provide adequate seizure control. The drug works by raising the seizure threshold and modulating neuronal firing. It is typically used under specialist guidance and requires monitoring due to potential side effects such as drowsiness, dizziness, and gastrointestinal discomfort.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Methsuximide — third party manufacturing & bulk supply

Methsuximide 150 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Methsuximide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Methsuximide →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Methsuximide is used for the treatment of absence (petit mal) seizures, mainly in patients who do not respond adequately to first-line anticonvulsant medications.

Methsuximide is made from the active pharmaceutical ingredient methsuximide, a succinimide derivative that works by suppressing abnormal electrical activity in the brain.

The main trade name is Celontin.

Celontin has historically been marketed by major pharmaceutical companies in the United States. Manufacturers may vary depending on the region and availability.

The generic name is methsuximide.

The brand name is Celontin.

Methsuximide is manufactured by different pharmaceutical companies in various countries depending on brand ownership and regional regulatory approvals.

Related Products

Valproic Acid

Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL

Form: Tablet / Capsule/ Injection / Oral syrup

Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)

View Details
Ubrogepant

Strength:
50 mg, 100 mg

Form: Tablets

Reference Brands: Ubrelvy (USA/India)

View Details
Tolcapone

Strength:
100 mg

Form: Tablets

Reference Brands: Tasmar (USA/EU)

View Details
Safinamide

Strength:
50 mg ,100 mg

Form: Tablets

Reference Brands: Xadago (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.